Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · IEX Real-Time Price · USD
0.294
+0.004 (1.38%)
At close: Apr 19, 2024, 4:00 PM
0.277
-0.017 (-5.71%)
After-hours: Apr 19, 2024, 7:22 PM EDT

Mangoceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022
Revenue
0.730.01
Revenue Growth (YoY)
8083.16%-
Cost of Revenue
0.30
Gross Profit
0.430
Selling, General & Admin
7.52
Other Operating Expenses
2.160
Operating Expenses
9.652
Operating Income
-9.22-1.99
Interest Expense / Income
00.01
Other Expense / Income
-0.01-
Pretax Income
-9.21-2
Net Income
-9.21-2
Shares Outstanding (Basic)
1611
Shares Outstanding (Diluted)
1611
Shares Change
49.22%-
EPS (Basic)
-0.57-0.19
EPS (Diluted)
-0.57-0.19
Free Cash Flow
-7-1.39
Free Cash Flow Per Share
-0.43-0.13
Gross Margin
58.99%54.26%
Operating Margin
-1260.28%-22279.70%
Profit Margin
-1259.40%-22352.11%
Free Cash Flow Margin
-957.07%-15545.59%
EBITDA
-9.19-1.99
EBITDA Margin
-1256.00%-22236.48%
Depreciation & Amortization
0.020
EBIT
-9.21-1.99
EBIT Margin
-1259.40%-22279.70%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).